Optimizing Quality of Life and Mental Health in Patients With Psoriasis
Program Introduction
Psoriasis and Psychological Comorbidities
Psoriasis: Psychosomatic Comorbidity Development
Development of Psoriasis: Psychosomatic Aspects
Results of SF-36 Quality of Life Inventory
Isolation, Anxiety, Depression: Ways to Solve the Psychosocial Problems in Psoriasis
Social Lives, Partnership, and Sexuality
Differences in the Appraisal of Touching Behavior Between Psoriasis Patients and Skin-Healthy Controls
Evaluation of Individual Risks for Comorbidities
Risk of Depression, Anxiety, and Suicidality
DSM, Diagnostic Criteria of Depression (by ICD-10 and DSM-5)
Clinical Features of the Most Common Anxiety Disorders in Psoriasis
Suicidal Thoughts and Common Skin Diseases
Common and Divergent Pathogenic Pathways of Depression, Anxiety, and Psoriasis
Balancing Patient Expectations vs Physician Objectives
Available Therapies for Psoriasis
Biologic Therapies for Psoriasis
PASI-75 and PASI-90 Responses
Psychodermatology Training
Six Basic Principles of Psychological-Based Interventions
Psoriasis and …
Explore and Explain How Brain and Psoriasis Interact
Summary
Abbreviations
Abbreviations (cont)